Stocks and Investing Stocks and Investing
Thu, February 25, 2016
[ 12:00 AM ] - United States, WOPRAI
Oliver Chen Maintained (TGT) at Buy with Increased Target to $86 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Paul Silverstein Maintained (AAOI) at Buy with Increased Target to $25 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Mohit Bansal Initiated (ADAP) at Strong Buy on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Rodolfo Angele Maintained (TX) at Buy with Increased Target to $18 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Brian Bedell Maintained (STT) at Hold with Increased Target to $56 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Susan Roth Katzke Maintained (BAC) at Buy with Decreased Target to $18 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Lloyd Walmsley Maintained (SSTK) at Hold with Increased Target to $41 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Brian Fitzgerald Maintained (SSTK) at Hold with Increased Target to $40 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Kevin Caliendo Upgraded (XRAY) to Hold and Held Target at $60 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Christopher Turnure Maintained (XEL) at Hold with Increased Target to $39 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
David Begleiter Maintained (WLKP) at Strong Buy with Decreased Target to $22 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
Omotayo Okusanya Maintained (VTR) at Hold with Decreased Target to $52 on, Feb 25th, 2016
[ 12:00 AM ] - United States, WOPRAI
George Bahamondes Maintained (SLRC) at Strong Buy with Decreased Target to $23 on, Feb 25th, 2016
Wed, February 24, 2016
[ 12:00 AM ] - United States, WOPRAI
Dave Rochester Maintained (CFR) at Hold with Increased Target to $57 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Alex Scott Maintained (VOYA) at Strong Buy on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Rob Oliver Maintained (WK) at Buy with Decreased Target to $15 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Dave Rochester Maintained (TCBI) at Strong Buy with Decreased Target to $52 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Douglas Tsao Maintained (TRVN) at Buy on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Connor Lynagh Downgraded (TS) to Hold and Increased Target to $26 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Michael Baker Maintained (TSCO) at Strong Buy with Decreased Target to $98 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Adrian Yanoshik Maintained (TSLA) at Strong Sell with Decreased Target to $2 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Michael Lewis Maintained (AIV) at Strong Buy with Decreased Target to $52 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
David Macdonald Maintained (THC) at Hold with Decreased Target to $28 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Dave Rochester Maintained (WBS) at Strong Buy with Decreased Target to $39 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Alex Yao Initiated (WB) at Buy and Held Target at $18 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Mark Marcon Maintained (WDAY) at Buy with Decreased Target to $75 on, Feb 24th, 2016
[ 12:00 AM ] - United States, WOPRAI
Jake Bartlett Downgraded (CBRL) to Hold on, Feb 24th, 2016
Tue, February 23, 2016
[ 12:00 AM ] - United States, WOPRAI
Binbin Ding Initiated (ATHM) at Hold on, Feb 23rd, 2016
[ 12:00 AM ] - United States, WOPRAI
Johann Steyn Upgraded (AU) to Hold on, Feb 23rd, 2016
[ 12:00 AM ] - United States, WOPRAI
Joseph Schwartz Maintained (BMRN) at Buy with Decreased Target to $120 on, Feb 23rd, 2016

Joseph Schwartz Maintained (BMRN) at Buy with Decreased Target to $120 on, Feb 23rd, 2016


Published on 2024-10-25 11:41:31 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of Leerink Swann, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $149 to $120 on, Feb 23rd, 2016.

Joseph has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph

  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $125 on, Friday, January 15th, 2016

Contributing Sources